UAE FIBROID Results Show Improvement, No Device Differences
This article was originally published in The Gray Sheet
Executive Summary
Initial results of patients treated with uterine artery embolization (UAE) in the FIBROID registry show significant improvements in symptoms and quality of life, but reveal no differences in outcome among the various device brands studied
You may also be interested in...
UAE FIBROID Registry Unlikely To Deliver Conclusive Post-Op Fertility Data
Insufficient data from the uterine artery embolization FIBROID registry will necessitate further investigation to assess the impact of the procedure on fertility and future pregnancies, according to James Spies, MD, Georgetown University Medical Center
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.